Keyphrases
Ovarian Cancer
100%
Drug Target
100%
Potential Biomarkers
100%
Tumor Cell Subpopulations
100%
Biomarkers of Response
100%
Epigenetic Drugs
100%
PTGIS
100%
Gene Expression
66%
Tumor Progression
66%
Residual Tumor
66%
Curcumin
66%
5-Aza-dC
66%
Genomic Instability
33%
Disease Management
33%
Cell Response
33%
Tumor Cells
33%
Tumor Suppressor
33%
Tumor Response
33%
Cancer Genome Atlas
33%
Clinical Significance
33%
Promoter Methylation
33%
Epigenetic Regulation
33%
Methylation
33%
Drug Treatment
33%
Epigenetic Modification
33%
Regeneration
33%
Genomic Profiling
33%
Cell Tumor
33%
In Silico Analysis
33%
Serous Ovarian Adenocarcinoma
33%
Multidrug-resistant
33%
Pathways in Cancer
33%
Histone Modification
33%
Drug Efficacy
33%
Regenerability
33%
Ovarian Cancer Progression
33%
Differentially Regulated Genes
33%
Drug Screening
33%
Mechanistic Understanding
33%
Tumor Heterogeneity
33%
Experimental Animal Models
33%
Genome-wide Analysis
33%
Histone Genes
33%
Cell Cycling
33%
Altered Gene Expression
33%
Progression Model
33%
Functional Interpretation
33%
Disrupted Pathways
33%
Progression Biomarkers
33%
Medicine and Dentistry
Biological Marker
100%
Tumor Cell
100%
Ovarian Cancer
100%
Drug Delivery System
100%
Gene Expression
50%
Neoplasm
33%
Tumor Progression
33%
Curcumin
33%
Malignant Neoplasm
16%
In Vitro
16%
Disease Management
16%
DNA Methylation
16%
The Cancer Genome Atlas
16%
Cancer Growth
16%
Promoter Region
16%
Drug Therapy
16%
Regeneration
16%
Tumor Suppressor Protein
16%
Methylation
16%
Histone Modification
16%
In Silico
16%
Ovary Adenocarcinoma
16%
Drug Screening
16%
Drug Efficacy
16%
Pharmacology, Toxicology and Pharmaceutical Science
Neoplasm
100%
Biological Marker
100%
Ovary Cancer
100%
Drug Delivery System
100%
Malignant Neoplasm
33%
Tumor Growth
33%
Curcumin
33%
Diseases
16%
Tumor Suppressor Protein
16%
Histone
16%
Cancer Growth
16%
Drug Screening
16%
Experimental Animal
16%
Pharmacotherapy
16%
Ovary Adenocarcinoma
16%
Biochemistry, Genetics and Molecular Biology
Epigenetics
100%
Drug Targeting
100%
Gene Expression
60%
Tumor Progression
40%
DNA Methylation
20%
Genetics
20%
Experimental Animal
20%
Tumor Suppressor Protein
20%
Promoter Region
20%
Methylation
20%
Animal Model
20%
Histone Modification
20%
Drug Efficacy
20%
Drug Therapy
20%
Drug Screening
20%